Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly FCF Margin came in at 20.15% in Q2 2026, down 1382.0% year-over-year from 1.57% in Q2 2025, and down 8.5% quarter-over-quarter from 22.02% in Q1 2026.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed FCF Margin across 17 years of filings, most recently posting 20.15% for Q2 2026.
- In Q2 2026, FCF Margin fell 1382.0% year-over-year to 20.15%; the TTM figure through Jun 2026 stood at 17.68% (up 90.0% YoY), while the FY2025 annual figure was 19.4%, up 1162.0% from the prior year.
- FCF Margin came in at 20.15% for Q2 2026 at Ani Pharmaceuticals, down from 22.02% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 33.97% in Q2 2025 to a low of 32.4% in Q1 2022.
- Average FCF Margin over 5 years is 10.28%, with a median of 13.67% recorded in 2023.
- Year-over-year, FCF Margin slumped 6903 bps in 2022 and surged 5026 bps in 2023.
- Over 5 years, FCF Margin stood at 8.0% in 2022, then soared by 503 bps to 32.25% in 2023, then slumped by 78 bps to 7.07% in 2024, then soared by 67 bps to 11.79% in 2025, then surged by 71 bps to 20.15% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 20.15% in Q2 2026, 22.02% in Q1 2026, and 11.79% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.79% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 20.15% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 14.76% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | -133.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.15% |
| Mar 31, 2026 | 22.02% |
| Dec 31, 2025 | 11.79% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | 33.97% |
| Mar 31, 2025 | 16.50% |
| Dec 31, 2024 | 7.07% |
| Sep 30, 2024 | 5.17% |
| Jun 30, 2024 | 9.39% |
| Mar 31, 2024 | 9.96% |
| Dec 31, 2023 | 32.25% |
| Sep 30, 2023 | 23.08% |
| Jun 30, 2023 | 15.55% |
| Mar 31, 2023 | 17.86% |
| Dec 31, 2022 | -8.00% |
| Sep 30, 2022 | 1.38% |
| Jun 30, 2022 | -17.34% |
| Mar 31, 2022 | -32.40% |
| Dec 31, 2021 | -20.58% |
| Sep 30, 2021 | -11.47% |